Insiders trading at Ambrx Biopharma
Over the last 2 years, insiders at Ambrx Biopharma have traded over $616,598 worth of Ambrx Biopharma stock and bought 12,273,134 units worth $123,242,196 . The most active insiders traders include Asset Management, Lp Chen B..., Daniel J. O'connor, and Paul V Maier. On average, Ambrx Biopharma executives and independent directors trade stock every 32 days with the average trade being worth of $49,343,700. The most recent stock trade was executed by Sonja Nelson on 27 October 2023, trading 12,778 units of AMAM stock currently worth $125,480.
What does Ambrx Biopharma's logo look like?
Ambrx Biopharma executives and stock owners
Ambrx Biopharma executives and other stock owners filed with the SEC include:
-
Dr. Janice Lu M.D., Ph.D.,
Chief Medical Officer -
Dr. Shawn Shao-Hui Zhang,
Sr. VP of R&D Operations and Ambrx China -
Simon J. Allen B.Sc., M.B.A., MBA,
Chief Bus. Officer -
Sonja Nelson CPA,
Chief Financial Officer -
Dr. Feng Tian Ph.D.,
Pres, Member of Scientific Advisory Board, CEO & Chairman -
Janet Loesberg,
-
Xiaowei Chang,
Director -
Global Management, Ltd. Darwin,
10% owner -
Stephen C. Glover,
-
Kate Hermans,
-
Paul V Maier,
-
Sonja Nelson,
Chief Financial Officer -
Katrin Rupalla,
Director -
Asset Management, Lp Chen B...,
-
Global Management, Ltd.Darw...,
-
Daniel J. O'connor,
President and CEO -
Andrew Aromando,
Chief Operating Officer